Skip to main content

General Aspects of the Biology and Function of Somatostatin

  • Conference paper
Somatostatin

Part of the book series: Basic and Clinical Aspects of Neuroscience ((BASIC,volume 4))

Abstract

Biological activity now recognizable as that of somatostatin (SS) was first encountered in 1968 by Krulich et al. [33] during attempts to screen hypothalamic extracts for growth hormone (GH) releasing activity. The workers identified a GH-inhibitory substance, characterized it as a low-molecular-weight basic peptide, and were able to localize the biological activity to the median eminence and anterior hypothalamic area. A year later, Hellman and Lernmark [23] reported the presence of a potent insulin-inhibitory factor in extracts of pigeon pancreatic islets. These two apparently unrelated observations were to come into sharp focus in 1973 with the discovery by Brazeau et al. [10] of the tetradecapeptide SS-14 as the hypothalamic GH-inhibitory substance, a signal achievement duly recognized by the award of the Nobel Prize to Guillemin in 1977. Subsequent studies revealed that SS is not produced only in the hypothalamus but also occurs throughout the central nervous system (CNS), in peripheral neurons, in the gastrointestinal (GI) tract and in the pancreatic islets of Langerhans. Furthermore, SS-like immunoreactivity is heterogeneous and is distributed in many tissues in both vertebrate and invertebrate species of the animal kingdom and in the plant kingdom. Extensive investigation of SS has shown that its wide anatomical distribution is paralleled by an equally broad spectrum of biological effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amherdt M, Patel YC, Orci L (1987) Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography. J Clin Invest 80: 1455–1458

    Article  PubMed  CAS  Google Scholar 

  2. Argos P, Taylor WL, Minth CD, Dixon JE (1983) Nucleotide and amino acid sequence comparisons of preprosomatostatins. J Biol Chem 258: 8788–8793

    PubMed  CAS  Google Scholar 

  3. Baetens D, Malaisse-Lagae F, Perrelet A, Orci L (1979) Endocrine pancreas: three dimensional reconstruction shows two types of islets of Langerhans. Science 206: 1323–1325

    Article  PubMed  CAS  Google Scholar 

  4. Beal MF (1990) Somatostatin in neurogenerative illnesses. Metabolism [Suppl 2] 39: 116–119

    Article  CAS  Google Scholar 

  5. Benoit R, Ling N. Esch F (1987) A new prosomatostatin derived peptide reveals a pattern for prohormone cleavage at monobasic sites. Science 238: 1126–1129

    Article  PubMed  CAS  Google Scholar 

  6. Berelowitz M, Dudlak D, Frohman LA (1982) Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. J Clin Invest 69: 1293–1301

    Article  PubMed  CAS  Google Scholar 

  7. Berelowitz M, Firestone S, Frohman LA (1981) Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution. Endocrinology 109: 714–719

    Article  PubMed  CAS  Google Scholar 

  8. Berelowitz M, Maeda K, Harris S, Frohman LEA (1980) The effect of alterations in the pituitary-thyroid axis on hypothalamic content and in vitro release of somatostatin-like immunoreactivity. Endocrinology 107: 24–29

    Article  PubMed  CAS  Google Scholar 

  9. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L (1981) Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212: 1279–1281

    Article  PubMed  CAS  Google Scholar 

  10. Brazeau P, Vale WW, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77–79

    Article  PubMed  CAS  Google Scholar 

  11. Chowen-Breed J, Steiner RA, Clifton DK (1989) Sexual dimorphism and testosterone dependent regulation of somatostatin gene expression in the periventricular nucleus of the rat brain. Endocrinology 125: 357–362

    Article  PubMed  CAS  Google Scholar 

  12. Colturi TJ, Unger RH, Feldman M (1984) Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest 74: 417–423

    Google Scholar 

  13. Critchlow V, Abe S, Urman S, Vale WW (1981) Effects of lesions of the periventricular nucleus of the preoptic-anterior hypothalamus on growth hormone and thyrotropin secretion and brain somatostatin. Brain Res 222: 267–276

    Article  PubMed  CAS  Google Scholar 

  14. D’Alessio DA, Sieber C, Beglinger C, Ensinck JW (1989) A physiologic role for somatostatin-28 as a regulator of insulin secretion. J Clin Invest 84: 857–862

    Article  PubMed  Google Scholar 

  15. Davies P, Katzman R, Terry RD (1980) Reduced somatostatin like immunoreactivity in cerebral cortex from cases of Alzheimer’s disease and Alzheimer senile dementia. Nature 288: 279–280

    Article  PubMed  CAS  Google Scholar 

  16. Epelbaum J (1986) Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol 27: 63–100

    Article  PubMed  CAS  Google Scholar 

  17. Finley JCW, Maderdrut JL, Roger LJ, Petrusz P (1981) The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous system. Neuroscience 6: 2173–2192

    Article  PubMed  CAS  Google Scholar 

  18. Funckes CL, Minth CD, Deschenes R, Magazin M, Tavianini MA, Sheets M, Collier K, Weith HL, Aron DL, Roos BA, Dixon JE (1983) Cloning and characterization of a mRNA encoding rat preprosomatostatin. J Biol Chem 258: 8781–8787

    PubMed  CAS  Google Scholar 

  19. Gerich JE (1990) Role of somatostatin and its analogues in the pathogenesis and treatment of diabetes mellitus. Metabolism [Suppl 2] 39: 52–54

    Article  CAS  Google Scholar 

  20. Goodman RH, Aron DC, Roos BA (1982) Rat preprosomatostatin: structure and processing by microsomal membranes. J Biol Chem 258: 5570–5573

    Google Scholar 

  21. Goodman RH, Rehfuss RP, Verhave M, Ventimiglia R, Low MJ (1990) Somatostatin gene regulation: an overview. Metabolism [Suppl 2] 39: 2–5

    Article  CAS  Google Scholar 

  22. Gyr K, Beglinger C, Kohler E, Trantzl U, Keller U, Bloom SR (1987) Circulating somatostatin: physiological regulator of pancreatic function? J Clin Invest 79: 1595–1600

    Article  PubMed  CAS  Google Scholar 

  23. Hellman B, Lernmark A (1969) Inhibition of the in vitro secretion of insulin by an extract of pancreatic al cells. Endocrinology 84: 1484–1487

    Article  PubMed  CAS  Google Scholar 

  24. Hobart P. Crawford R, Shen L-P, Pictet R, Rutter WJ (1980) Cloning and sequence analysis of cDNAs encoding two distinct somatostatin precursors found in the endocrine pancreas of anglerfish. Nature 288: 137–141

    Article  PubMed  CAS  Google Scholar 

  25. Horvath S, Palkovits M, Gores T, Arimura A (1989) Electron microscopic immunocytochemical evidence for the existence of bidirectional synaptic connections between growth hormone releasing hormone-and somatostatin-containing neurons in the hypothalamus of the rat. Brain Res 481: 8–15

    Article  PubMed  CAS  Google Scholar 

  26. Ikeda SR, Schofield GG (1989) Somatostatin blocks a calcium current in rat sympathetic ganglion neurones. J Physiol (Lond) 409: 221–240

    CAS  Google Scholar 

  27. Johansson O, Hokfelt T, Elde RP (1984) Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience 13: 265–339

    Article  PubMed  CAS  Google Scholar 

  28. Katakami H, Arimura A, Frohman LA (1986) Growth hormone (GH)-releasing factor stimulates hypothalamic-somatostatin release: an inhibitory feedback effect on GH secretion. Endocrinology 118: 1872–1877

    Article  PubMed  CAS  Google Scholar 

  29. Katakami H, Downs TR, Frohman LA (1988) Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone releasing factor in the rat. Endocrinology 123: 1103–1109

    Article  PubMed  CAS  Google Scholar 

  30. Kawai K, Orci L, Ipp E, Perrelet A, Unger RH (1982) Circulating somatostatin acts on the islets of Langerhans via a somatostatinpoor compartment. Science 218: 477–478

    Article  PubMed  CAS  Google Scholar 

  31. Krejs GJ, Orci L, Conlon JM, Ravazzola M. Davis GR, Ruskin P, Collins SM, McCarthy DM, Baetens D, Rubenstein A, Aldor TAM, Unger RH (1979) Somatostatinoma syndrome: biochemical, morphological and clinical features. N Engl J Med 301: 285–292

    Article  PubMed  CAS  Google Scholar 

  32. Krisch B (1979) Immunohistochemical results on the distribution of somatostatin in the hypothalamus and in limbic structures of the rat. J Histochem Cytochem 27: 1389–1390

    Article  PubMed  CAS  Google Scholar 

  33. Krulich L, Dhariwal APS, McCann SM (1968) Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 83: 783–790

    Article  PubMed  CAS  Google Scholar 

  34. Larsson LI (1985) Distribution and morphology of somatostatin cells. Adv Exp Biol Med 188: 383–402

    CAS  Google Scholar 

  35. Liebow C, Reilly C, Serrano M, et al. (1989) Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA 86: 2003–2007

    Article  PubMed  CAS  Google Scholar 

  36. Luini A, de Matteis MA (1990) Evidence that receptor-linked G protein inhibits exocytosis by a post-second messenger mechanism in AtT-20 cells. J Neurochem 54: 30–38

    CAS  Google Scholar 

  37. Mackin RB, Noe BD (1987) Direct evidence for two distinct prosomatostatin converting enzymes. J Biol Chem 262: 6453–6456

    PubMed  CAS  Google Scholar 

  38. Magazin M, Minth CD, Funckes CL, Deschenes R, Tavianini MA, Dixon JE (1982) Sequence of a cDNA encoding pancreatic preprosomatostatin-22. Proc Natl Acad Sci USA 79: 51. 52–5156

    Google Scholar 

  39. Makhlouf GM, Shubert ML (1990) Gastric somatostatin: a paracrine regulator of acid secretion. Metabolism [Suppl 2] 39: 138–142

    Article  CAS  Google Scholar 

  40. Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, Brazeau P, Bohlen P, Esch F, Guillemin R (1981) Selective effects of somatostatin-14, -25, and -28 on in vitro insulin and glucagon secretion. Nature 291: 76–77

    Article  PubMed  CAS  Google Scholar 

  41. McDonald JK, Greiner F, Bauer GE, Elde RP, Noe BD (1987) Separate cell types that express two different forms of somatostatin in anglerfish islets can be immunohistochemically differentiated. J Histochem Cytochem 35: 155–162

    Article  PubMed  CAS  Google Scholar 

  42. Montminy MR, Goodman RH, Horovitch SJ, Habener JF (1984) Primary structure of the gene encoding rat preprosomatostatin. Proc Natl Acad Sci USA 81: 3337–3340

    Article  PubMed  CAS  Google Scholar 

  43. Montminy MR, Gonzalez GA, Yamamoto KK (1990) Characteristics of the cAMP response unit. Metabolism [Suppl 2] 39: 6–12

    Article  CAS  Google Scholar 

  44. Noe BD, Debo G, Spiess J (1984) Comparison of prohormone processing activities in islet microsomes and secretory granules: evidence for distinct converting enzymes for separate islet prosomatostatin. J Cell Biol 99: 578–587

    Article  PubMed  CAS  Google Scholar 

  45. Papachristou DN, Patel YC (1988) Glucocorticoid (GL) regulation of somatostatin (S) gene expression in normal tissues and in a S-producing tumor cell line (1027 B2). In: Program Annual Meeting Society For Neuroscience, Toronto, Canada, vol 14, part I, p 17 (Abstr 11. 5 )

    Google Scholar 

  46. Patel SC, Papachristou DN, Patel YC (1991) Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons. J Neurochem 56: 1286–1291

    Article  PubMed  CAS  Google Scholar 

  47. Patel YC (1990) Somatostatin. In: Becker K (ed) Principles and practice of endocrinology and metabolism. Lippincott, Philadelphia, pp 1297–1301

    Google Scholar 

  48. Patel YC, Amherdt M, Orci L (1982) Quantitative electron micro-scopic radiography of insulin, glucagon and somatostatin binding sites on islets. Science 217: 1155–1156

    Article  PubMed  CAS  Google Scholar 

  49. Patel YC, Murthy KK, Escher E, Banville D, Spiess J, Srikant CB (1990) Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism [Suppl 2] 39: 63–69

    Article  CAS  Google Scholar 

  50. Patel YC, O’Neil W (1988) Peptides derived from cleavage of prosomatostatin at carboxy and amino terminal segments: characterization of tissue and secreted forms in the rat. J Biol Chem 263: 745–751

    PubMed  CAS  Google Scholar 

  51. Patel YC, Papachristou DN, Zingg HH, Farkas EM (1991) Regulation of islet somatostatin secretion and gene transcription: selective effects of cAMP and phorbol esters in normal islets and in a somatostatin producing rat islet clonal cell line (1027 B2). Endocrinology 128: 1754–1762

    Article  PubMed  CAS  Google Scholar 

  52. Patel YC, Pierzchala I, Amherdt M, Orci L (1985) Effects of cysteamine and antibody to somatostatin on islet cell function in vitro: evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion. J Clin Invest 75: 1249–1255

    Article  PubMed  CAS  Google Scholar 

  53. Patel YC, Prakash MLS, Papachristou DN, Farkas EM, Pham K (1988) Insulin is a potent inhibitor of somatostatin secretion and mRNA accumulation in a somatostatin-producing islet tumor cell line. Diabetes [Suppl 1] 37: 101 A

    Google Scholar 

  54. Patel YC, Rao K, Reichlin S (1977) Somatostatin in human cerebrospinal fluid. N Engl J Med 296: 529–533

    Article  PubMed  CAS  Google Scholar 

  55. Patel YC, Reichlin S (1978) Somatostatin in hypothalamus, extrahypothalamic brain and peripheral tissues of the rat. Endocrinology 102: 523–530

    Article  PubMed  CAS  Google Scholar 

  56. Patel YC, Srikant CB (1985) Somatostatin mediation of adenohypophysial secretion. Annu Rev Physiol 48: 551–567

    Article  Google Scholar 

  57. Patel YC, Tannenbaum GS (eds) (1985) Somatostatin. Adv Exp Med Bio1188

    Google Scholar 

  58. Patel YC, Tannenbaum GS (eds) (1990) Somatostatin. Basic and clinical aspects. Metabolism [Suppl 2] 39

    Google Scholar 

  59. Patel YC, Wheatley T, Ning C (1981) Multiple forms of immunoreactive somatostatin: comparison of distribution in neural and non-neural tissues and portal plasma of the rat. Endocrinology 109: 1943–1949

    Article  PubMed  CAS  Google Scholar 

  60. Peterfreund RA, Vale WW (1985) Somatostatin secretion from the hypothalamus. Adv Exp Med Biol 188: 183–200

    PubMed  CAS  Google Scholar 

  61. Plotsky PM, Vale WW (1 985) Patterns of growth hormone releasing factor and somatostatin secretion into hypophysial portal circulation of the rat. Science 230: 461–463

    Google Scholar 

  62. Rabbani SN, Patel YC (1 988) Measurement and characterization of somatostatin-14 like immunoreactivity in human urine. J Clin Endocrinol Metab 66: 1050–1055

    Google Scholar 

  63. Rabbani SN, Patel YC (1990) Peptides derived by processing of rat prosomatostatin near the amino terminus: characterization, tissue distribution and release. Endocrinology 126: 2054–2061

    Article  PubMed  CAS  Google Scholar 

  64. Reichlin S (1983) Somatostatin. N Engl J Med 309: 1495–1501, 1556–1563

    Google Scholar 

  65. Reichlin S (ed) (1987) Somatostatin basic and clinical status. Plenum, New York

    Google Scholar 

  66. Reubi JC, Kvols L, Krenning E, Lamberts SWJ (1990) Distribution of somatostatin receptors in normal and tumor tissue. Metabolism [Suppl 2] 39: 78–81

    Article  CAS  Google Scholar 

  67. Riekkinen P, Pitkanen A (1990) Somatostatin and epilepsy. Metabolism [Suppl 2] 39: 112–115

    Article  CAS  Google Scholar 

  68. Rogers KV, Vician L, Steiner RA, Clifton DK (1988) The effect of hypophysectomy and growth hormone administration on preprosomatostatin messenger ribonucleic acid in the periventricular nucleus of the rat hypothalamus. Endocrinology 122: 586–590

    Article  PubMed  CAS  Google Scholar 

  69. Rubinow DR, Gold PW, Post RM, Ballenger JC, Cowdry R, Rollinger J, Reichlin S (1983) CSF somatostatin in affective illness. Arch Gen Psychiatry 40: 409–412

    PubMed  CAS  Google Scholar 

  70. Samols E, Stagner JI (1990) Islet somatostatin–microvascular, paracrine and pulsatile regulation. Metabolism [Suppl 2] 39: 55–60

    Article  CAS  Google Scholar 

  71. Sasaki A, Yoshinaga K (1989) Immunoreactive somatostatin in male reproductive system in humans. J Clin Endocrinol Metab 68: 996–999

    Article  PubMed  CAS  Google Scholar 

  72. Scarborough DE (1990) Somatostatin regulation by cytokines. Metabolism [Suppl 2] 39: 108–111

    Article  CAS  Google Scholar 

  73. Schonbrunn A (1990) Somatostatin action in pituitary cells involves two independent transduction mechanisms. Metabolism [Suppl 2] 39: 96–100

    Article  CAS  Google Scholar 

  74. Sevarino KA, Stork P, Ventimeglia R, Mandel G, Goodman RH (1989) Processing and intracellular sorting of anglerfish and rat preprosomatostatins in mammalian endocrine cells. Cell 57: 11–19

    Article  PubMed  CAS  Google Scholar 

  75. Shen L-P, Pictet RL, Rutter WJ (1982) Human somatostatin. I. Sequence of the cDNA. Proc Natl Acad Sci USA 79: 4575–4579

    Google Scholar 

  76. Shoelson SE, Polonsky KS, Nakabayashi T, Jaspan JB, Tager HS (1986) Circulating forms of somatostatin-like immunoreactivity in human plasma. Am J Physiol 250: E428 - E434

    PubMed  CAS  Google Scholar 

  77. Skamene A, Patel YC (1984) Infusions of graded concentrations of somatostatin-14 in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones. Clin Endocrinol (Oxf) 20: 555–564

    Article  CAS  Google Scholar 

  78. Srikant CB, Patel YC (1987) Somatostatin receptors: evidence for functional and structural heterogeneity. In: Reichlin S (ed) Proceedings of the International Conference on Somatostatin. Plenum, New York, pp 89–102

    Google Scholar 

  79. Taborsky GJ (1983) Evidence of a paracrine role for pancreatic somatostatin in vivo. Am J Physiol 245: E598 - E603

    PubMed  CAS  Google Scholar 

  80. Tannenbaum GS, McCarthy GF, Zeitler P, Beaudet A (1990) Cysteamine induced enhancement of growth hormone releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus. Endocrinology 127: 2551–2560

    Article  PubMed  CAS  Google Scholar 

  81. Tannenbaum GS, Painson J-C, Lapointe M, Gurd W, McCarthy GF (1990) Interplay of somatostatin and growth hormone releasing hormone in genesis of episodic growth hormone secretion. Metabolism [Suppl 2] 39: 35–39

    Article  CAS  Google Scholar 

  82. Taylor WL, Collier KJ, Deschenes RJ, Weith HL, Dixon JE (1981) Sequence analysis of a cDNA coding for a pancreatic precursor to somatostatin. Proc Natl Acad Sci USA 78: 6694–6698

    Article  PubMed  CAS  Google Scholar 

  83. Thorner MO, Vance ML, Hartman ML, Hall RW, Evans WS, Veld-huis JD, van Cauter E, Copinschi G, Bowers CY (1990) Physiological role of somatostatin on growth hormone regulation in humans. Metabolism [Suppl 2] 39: 40–42

    Article  CAS  Google Scholar 

  84. Wang H-L, Bogen C, Reisine T, Dichter M (1989) Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons. Proc Natl Acad Sci USA 86: 9616–9620

    Article  PubMed  CAS  Google Scholar 

  85. Weir GC, Bonner-Weir S (1985) Pancreatic somatostatin. Adv Exp Med Biol 188: 403–423

    PubMed  CAS  Google Scholar 

  86. Werner H, Koch Y, Baldino F Jr, Gozes I (1988) Steroid regulation of somatostatin mRNA in the rat hypothalamus. J Biol Chem 263: 7666–7674

    PubMed  CAS  Google Scholar 

  87. Wollheim CB, Winiger BP, Ullrich S, et al. (1990) Somatostatin inhibition of hormone release: effects on cytosolic Ca“ and interference with distal secretory events. Metabolism [Suppl 1] 39: 101–104

    CAS  Google Scholar 

  88. Yamada T (1987) Gut somatostatin. In: Reichlin S (ed) Somatostatin. Basic and clinical status. Plenum, New York, pp 221–228

    Google Scholar 

  89. Yatani A, Codina J, Sekura RD, et al. (1987) Reconstitution of somatostatin and muscarinic receptor mediated stimulation of K’ channels by isolated Gk protein in clonal rat anterior pituitary cell membranes. Mol Endocrinol 1: 283–289

    Article  PubMed  CAS  Google Scholar 

  90. Zyznar E, Pietri A, Harris V, Unger RH (1981) Evidence for the hormonal status of somatostatin in man. Diabetes 30: 883–886

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Patel, Y.C. (1992). General Aspects of the Biology and Function of Somatostatin. In: Somatostatin. Basic and Clinical Aspects of Neuroscience, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76948-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76948-1_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54569-9

  • Online ISBN: 978-3-642-76948-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics